⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28859409 | 0.97 | — | — | |
| Acetone SCHEMBL819001 | 0.95 | TSHR (0.60) | — | |
| Acetic Acid SCHEMBL8981897 | 0.90 | TSHR (0.55) | — | |
| SCHEMBL827890 | 0.83 | — | — | |
| SCHEMBL5098798 | 0.81 | — | — | |
| SCHEMBL8407685 | 0.81 | TSHR (0.44) | — | |
| Biphenyl SCHEMBL28779297 | 0.81 | ALDH1A1 (0.47) | — | |
| Dimethyl Succinate SCHEMBL10213 | 0.81 | TSHR (1.00) | — | |
| SCHEMBL4334523 | 0.79 | TSHR (0.64) | — | |
| SCHEMBL9244508 | 0.79 | TSHR (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117964584-A | Synthesis method of (R) -4-propyl-dihydrofuran-2-one | 江苏同禾药业有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-110615859-B | Preparation method of sodium gluconate | 鲁南制药集团股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-112759866-B | Method for preparing migration-resistant bio-based plasticizer by continuously increasing ester of kitchen recovered oil | 四川大学 | 2022-01-25 | — | — | CN | claimed |
| CN-112759866-A | Method for preparing migration-resistant bio-based plasticizer by continuously increasing ester of kitchen recovered oil | 四川大学 | 2021-05-07 | — | — | CN | claimed |
| CN-108624080-B | Near-infrared dye | 青岛大学 | 2020-03-10 | — | — | CN | claimed |
| CN-108624080-A | Near-infrared dye | 青岛大学 | 2018-10-09 | — | — | CN | claimed |
| CN-108299443-A | The synthesis technology for the first time of octahydro -5H- pyrrolo-es [1,2-A] [1,4] diazepine -5- ketone | 江苏正大清江制药有限公司 | 2018-07-20 | — | — | CN | claimed |
| US-8178712-B2 | Process for the synthesis of Ibandronate sodium | CIPLA LTD. (IN) | 2012-05-15 | — | — | US | claimed |
| US-20100228052-A1 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | CIPLA LTD. (IN) | 2010-09-09 | — | — | US | claimed |
| EP-2038291-B1 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | CIPLA LTD (IN) | 2010-07-14 | — | — | EP | claimed |
| EP-2038291-A2 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | Cipla Limited (IN) | 2009-03-25 | — | — | EP | claimed |
| WO-2008035367-A2 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | CIPLA LTD. (IN) | 2008-03-27 | — | — | WO | claimed |
| JP-7324061-A | — | — | None | — | — | JP | disclosed |
| US-20240279197-A1 | NRF2 ACTIVATOR | BIOGEN MA INC. | 2024-08-22 | — | — | US | disclosed |
| CN-117964584-A | Synthesis method of (R) -4-propyl-dihydrofuran-2-one | 江苏同禾药业有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117964584-A | Synthesis method of (R) -4-propyl-dihydrofuran-2-one | 江苏同禾药业有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-4281010-A | FOR INCREASING BLOOD CIRCULATION | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1981-07-28 | — | — | US | disclosed |
| US-4254269-A | PRECURSERS FOR CARDIOVASCULAR DRUGS | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1981-03-03 | — | — | US | disclosed |
| US-4206213-A | IMPROVING PERIPHERAL AND CEREBRAL CIRCULATION | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-06-03 | — | — | US | disclosed |
| US-4175088-A | Process for the production of [1,1-dithienyl-(3)-1-hydroxypropyl-(3)]-[1-phenyl-1-hydroxypropyl-(2)]-amine and [1,1-dithienyl-(3)-propen-(1)-yl-(3)]-[1-phenylpropyl-(2)]-amine | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-11-20 | — | — | US | disclosed |